Antibiotice, a profitable company

The investments in research and quality as well as for updating the manufacturing technologies have turned Antibiotice into a profitable, dynamic, investor-attractive company.


The Hippocratic spirit that guides the practice of medicine and pharmacy, also guides our actions. We are honest, compassionate and constantly concerned with modernizing our activity and enhancing our products. We believe a valuable medicine is one that people can afford.


We make our valuable medicines more accessible to patients, physicians and pharmacists. The patients’ wellbeing is in our best interest, and we always put our strength to the service of those who need support.

  • US Food and Drug Administration (FDA) approval for Ampicillin for injection (4 strengths) and Nystatin (API)
  • Eight GMP-certified manufacturing lines